How to Choose a Compounded Semaglutide Provider: What to Look For
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products and may differ in formulation, purity, and potency.
Search for where to get compounded semaglutide or tirzepatide and you will find a long list of programs all calling themselves the best. “Best” is not a useful filter, because anyone can claim it. What actually helps is a set of objective, checkable criteria you can hold every program to. This guide gives you that checklist, the red flags that should end your search, and the questions to ask before you hand over any information or payment.
Why “best” is the wrong question
There is no single best compounded GLP-1 provider, the same way there is no single best primary care office. The right provider is the one that is legitimate, transparent, and a fit for your situation. Marketing superlatives ("#1," “best,” “top-rated”) are not verifiable and tell you nothing about the two things that actually matter: the quality of the medical care and the quality of the pharmacy behind the medication.
So instead of asking “who is the best,” ask “does this program meet the criteria a responsible program should meet.” Those criteria are concrete, and you can check them before you hand over any information or payment.
The criteria that actually matter
Hold every program you consider to this list.
A licensed prescriber in your state. Telehealth prescribers generally need a license in the state where you are located when you are treated. Ask who the prescriber is (a physician, nurse practitioner, or physician assistant) and in which state they are licensed. You can look up a license on your state’s medical, nursing, or physician assistant board website.
A real prescription process. A licensed provider should review your health history and current medications and decide whether a compounded GLP-1 medication is appropriate before anything is prescribed. If a website offers to ship medication with no health questions and “no prescription needed,” that is disqualifying. The FDA advises getting a prescription from a licensed provider and filling it at a state-licensed pharmacy[2].
A named, licensed pharmacy. Ask which pharmacy prepares the medication and what type it is. A 503A pharmacy is licensed by the state and compounds for individual patients with a prescription. A 503B outsourcing facility is registered with the FDA and must follow current good manufacturing practice (CGMP) requirements. You can check a pharmacy’s license on its state board of pharmacy website, and you can check whether a facility appears on the FDA’s list of registered outsourcing facilities[3]. If you are unsure what those categories mean, see 503A vs 503B pharmacies.
Answers about testing and quality. Ask whether the pharmacy tests each batch for potency, purity, and sterility, and whether you can see a certificate of analysis for the batch you receive. Some pharmacies also hold voluntary PCAB (Pharmacy Compounding Accreditation Board) accreditation. Our guide to choosing a safe compounding pharmacy walks through how to check these.
The right active ingredient. The FDA has said that some semaglutide sold by compounders may be a salt form, such as semaglutide sodium or semaglutide acetate, which are different active ingredients from the one in FDA-approved products, and that it is not aware of a lawful basis for compounding with them[2]. Ask what form of the active ingredient the pharmacy uses and where it comes from.
Medical follow-up, and labs if required. Some programs require baseline lab work; others ask you to get labs through your own provider. Ask whether a licensed provider follows up during treatment, how dose changes are handled, and whether labs are included or billed separately.
Total cost and cancellation terms in writing. Prices vary by program and dose. Before you commit, ask for the total cost: medication at your likely dose, dose increases, provider visits, labs, shipping, membership fees, and cancellation terms. If a site will not tell you clearly what is included, something is usually billed separately.
Ongoing support, not just a first shipment. Ask how refills, dose adjustments, and questions are handled after the first order. See how delivery and refills typically work.
Honesty about regulatory status. A trustworthy program is clear that compounded medications are not FDA-approved and are not the same as brand-name products. Be wary of any program that leaves out that distinction or blurs it in marketing.
Red flags that should end your search
If you see any of these, keep looking:
- Medication offered with no prescription and no provider evaluation
- An unnamed pharmacy, or one based overseas
- Products labeled “for research purposes,” “research use only,” or “not for human consumption” (the FDA has warned companies that sell GLP-1 drugs this way[2])
- A pharmacy that will not say what form of the active ingredient it uses
- No provider follow-up and no way to reach anyone with questions
- A price that seems far too low, with no clear list of what is included
- Specific weight-loss numbers advertised up front, instead of results framed as varying by person
- Marketing that blurs the distinction between a compounded medication and a brand-name product
Any one of these is a reason to walk away. For more on separating legitimate programs from risky ones, see is compounded semaglutide legit. The FDA’s BeSafeRx campaign has more on buying prescription medicines online safely.
Provider vs pharmacy: know the difference
When you evaluate a program, you are really evaluating two things at once.
The provider is the licensed prescriber who reviews your health history and decides whether a compounded GLP-1 medication is appropriate, usually working through a telehealth program that handles scheduling, messaging, and billing. The pharmacy is the state-licensed compounding pharmacy or FDA-registered outsourcing facility that prepares your medication. A well-run program is transparent about both, because the quality of care and the quality of the medication depend on each. If a program is vague about either one, that is a gap worth noticing.
Program options to review
Transformation Health does not rank or recommend compounded GLP-1 programs on this page. When you look at any program, use these questions to compare them on the same terms:
- Prescriber. Who reviews my health history, what is their role, and are they licensed in my state?
- Pharmacy. Which pharmacy prepares the medication, is it a 503A pharmacy or a 503B outsourcing facility, and where can I look up its license or registration?
- Testing. Is each batch tested, and can I see a certificate of analysis?
- Active ingredient. What form of semaglutide or tirzepatide is used, and is it a salt form?
- Cost. What is the total monthly cost at my starting dose and at higher doses, and what is billed separately?
- Cancellation. Is there a minimum commitment or prepay requirement, and how do I cancel?
- Follow-up. How do I reach a provider with questions or side effects, and how are dose changes handled?
- Regulatory status. Does the program say clearly that compounded medications are not FDA-approved?
Transformation Health does not accept payment from providers. How we make money.
For what drives the price, see what compounded semaglutide costs, and for the step-by-step process, see how to get compounded semaglutide or how to get compounded tirzepatide.
How the process should work
At most telehealth programs, you fill out a health history form, a licensed provider reviews it and decides whether a prescription is appropriate, and, if one is written, a licensed pharmacy prepares the medication and ships it to you. A proper program includes follow-up with a licensed provider while you take it. Some programs use a live video visit rather than a form alone; ask whether one is required where you live.
We're relaunching soon
We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.
Get StartedImportant disclosures
This content is for general education and is not medical advice. Talk with a licensed provider about your situation.
Compounded semaglutide and tirzepatide are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed[2]. They are not the same as brand-name products, which went through FDA review, and they may differ in formulation, purity, and potency. You cannot assume compounded and brand-name versions will produce the same results.
Regulatory status is subject to change. On December 19, 2024, the FDA reissued its determination that the tirzepatide injection shortage was resolved; it said its enforcement discretion period for 503A pharmacies ended after a March 5, 2025 court decision and for 503B outsourcing facilities on March 19, 2025[1]. On February 21, 2025, the FDA determined that the semaglutide injection shortage was resolved; it said its 503A period ended after an April 24, 2025 court decision (the original end date was April 22, 2025) and its 503B period ended May 22, 2025[1]. The FDA page was most recently updated April 1, 2026; check it for the current statement[1]. Availability of compounded GLP-1 medications depends on federal and state law and FDA action, and cannot be guaranteed.
Results vary, and weight loss is not guaranteed. This page is general information to help you evaluate programs. It is not a claim that any provider is superior to another.
Citations
[1] U.S. Food and Drug Administration. “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” Content current as of 04/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (Accessed 2026-10-16.)
[2] U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Content current as of 10/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss (Accessed 2026-10-16.)
[3] U.S. Food and Drug Administration. “Registered Outsourcing Facilities.” https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities (Accessed 2026-10-16.)
Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Transformation Health is an independent GLP-1 guide. It does not provide medical care, prescribe, compound, or sell medication. A licensed provider decides whether a prescription is appropriate. Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products and may differ in formulation, purity, and potency. Results vary. Availability of compounded GLP-1 medications depends on FDA policy and applicable state and federal pharmacy compounding laws, which may change. Transformation Health does not accept payment from providers. How we make money.